Review
World J Hematol
2(3):62-70.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.62
Abstract (2830)
|
Core Tip (2042)
|
Full Article (HTML) (58740)
|
Figures (1-9) (1792)
|
Full Article (PDF)-576K (2669)
|
Peer-Review Report-178K (532)
|
Answering Reviewers-107K (515)
|
Received: 04/01/2013
|
Revised: 05/14/2013
|
Accepted: 06/10/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (12)
|
Total Visits (74192)
|
Similar Articles (16)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms
World J Hematol
2(3):71-88.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.71
Abstract (2092)
|
Core Tip (1815)
|
Full Article (HTML) (10821)
|
Figures (1-10) (745)
|
Tables (1-6) (620)
|
Full Article (PDF)-3685K (1115)
|
Peer-Review Report-98K (518)
|
Answering Reviewers-50K (424)
|
Received: 01/11/2013
|
Accepted: 06/18/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (21767)
|
Similar Articles (5)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hematol
2(3):89-98.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.89
Abstract (2056)
|
Core Tip (1729)
|
Full Article (HTML) (9154)
|
Figures (1-6) (679)
|
Tables (1-2) (457)
|
Full Article (PDF)-1438K (866)
|
Peer-Review Report-192K (334)
|
Answering Reviewers-63K (363)
|
Received: 03/11/2013
|
Revised: 05/10/2013
|
Accepted: 06/06/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (19342)
|
Similar Articles (35)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
